Agree about long term value being demonstrated but even in the...

Agree about long term value being demonstrated but even in the absence of that just another deal coming through with an up front would be a gee up for confidence in the future of this company.

Getting that one deal (Roche) really was a huge confidence booster to laymen investing in this stock as lets face it, (for the laymen) its harder to grasp the potential applications for this technology compared to other biotech applications that are ultimately consumer products like say a drug delivery patch or a new kind of pain relief pill.

Getting that first deal also made the probability of multiple clients being snared go up considerably.

Two clients increases the probability of obtaining a third and so on.

Form the Quarterly they are on track.

Supposedly two new deals in the pipeline to be announced soon

Bring on that next deal !